Navagant Receives Eight Nominations For Annual M&A Advisors Awards
September 2025 – We’re proud to share that Navagant has been named a finalist in the 24th Annual M&A Advisor Awards across multiple categories, recognizing our work in education, healthcare, and technology.
Atlantis
HEALTHCARE/LIFE SCIENCES DEAL OF THE YEAR (UNDER $100MM)
CORPORATE/STRATEGIC DEAL OF THE YEAR ($25MM TO $50MM)
Shemmassian Academic Consulting
CONSUMER DISCRETIONARY DEAL OF THE YEAR (UNDER $100MM)
PRIVATE EQUITY DEAL OF THE YEAR ($25MM TO $50MM)
Medality
CORPORATE/STRATEGIC DEAL OF THE YEAR ($50MM TO $100MM)
INFORMATION TECHNOLOGY DEAL OF THE YEAR ($50MM TO $100MM)
RAIN Group
PROFESSIONAL SERVICES DEAL OF THE YEAR ($25MM TO $100MM)
Elsmere Education
EQUITY FINANCING DEAL OF THE YEAR
Navagant
MID SIZE BOUTIQUE INVESTMENT BANKING FIRM OF THE YEAR
About Navagant
Navagant is a middle-market investment bank serving entrepreneurs, family-businesses, large corporations, and financial sponsors seeking to optimize their transaction outcomes. Our sell-side advisory services include mergers and acquisitions, majority and minority recapitalizations, management buyouts and corporate carve-outs. With a conscious-capital mission and a team of experienced investment banking professionals, Navagant delivers tailored solutions to help organizations unlock value and achieve life-changing outcomes.
For more information, please visit www.navagant.com.
Contact
Jacob Voorhees
Managing Director, Navagant
Phone: (617) 216-1543
jacob@navagant.com
About Navagant
Navagant is a middle-market investment bank serving entrepreneurs, family-businesses, large corporations, and financial sponsors seeking to optimize their transaction outcomes. Our sell-side advisory services include mergers and acquisitions, majority and minority recapitalizations, management buyouts and corporate carve-outs. With a conscious-capital mission and a team of experienced investment banking professionals, Navagant delivers tailored solutions to help organizations unlock value and achieve life-changing outcomes.
For more information, please visit www.navagant.com.
